An ultrasensitive electrochemical biosensor was developed to identify the low levels of uric acid (UA) in human serum. The gold/cobalt (Au/Co) bimetallic nanoparticles (NPs) decorated hollow nanoporous carbon framework (Au/Co@HNCF) was synthesized as a nanozyme by pyrolysis of the Au (III)-etching zeolitic imidazolate framework-67 (ZIF-67). The external Au NPs combined with internal Co NPs on the hollow carbon framework exhibited enhanced activity for UA oxidation, thereby generating superior signals. Accordingly, the Au/Co@HNCF biosensor presented ranking performances with a low detection limit of 0.023 μM (S/N = 3), an ultrahigh sensitivity of 48.4 μA μM^-1 cm^-2, and an extensive response in the linear region of 0.1–25 μM and the logarithmic region of 25–2500 μM. Owing to the ordered nanoporous framework and carbon interfacial features, the Au/Co@HNCF biosensor displayed adequate selectivity for UA sensing over a series of biomolecules. In addition, the Au/Co@HNCF biosensor was employed to quantify UA in human serum samples. The test results were basically consistent with those of a commercial apparatus, and thus demonstrated that the proposed Au/Co@HNCF biosensor was reliable for UA determination in clinical research.